Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Unknown 3Not yet recruiting 3Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Classical hematology 3

Conditions

Thrombocytopenia 2Digestive System Diseases 1Chemotherapy-induced Thrombocytopenia 1

Interventions

Cisplatin 270Oxaliplatin 195Carboplatin 191Capecitabine 184Docetaxel 178apatinib 164Paclitaxel 163Bevacizumab 159Gemcitabine 156Radiotherapy 147camrelizumab 146Fluorouracil 144Cyclophosphamide 126Irinotecan 120Drug Therapy 119sintilimab 108Etoposide 99anlotinib 90S 1 (combination) 89Leucovorin 86pembrolizumab 85toripalimab 78Pemetrexed 78Doxorubicin 77tislelizumab 76Dexamethasone 71Trastuzumab 65Neoadjuvant Therapy 65Rituximab 62Cetuximab 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Unknown × hetrombopag × Clear all
NCT05442632 2024-03-13

Efficacy and Safety of Herombopag in Patients With Thrombocytopenia Before Hepatectomy

Fudan University

Phase 2 Unknown
96 enrolled
Classical hematology

Digestive System Diseases, Thrombocytopenia

NCT06099925 2023-10-25

The Efficacy and Safety of Hetrombopag as Secondary Prevention to Chemotherapy-induced Thrombocytopenia in Patients With Gynecologic Malignancies

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Unknown
48 enrolled
Classical hematology

Chemotherapy-induced Thrombocytopenia

NCT06036966 2023-09-14

The Efficacy and Safety of Hetrombopag in Primary Prevention of Thrombocytopenia Induced by the Niraparib Maintenance in Advanced Ovarian Cancer Patients

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Unknown
34 enrolled
Classical hematology

Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡